Biomarkers currently play an important role in the detection and management of patients
with several different types of gastrointestinal cancer, especially colorectal, gastric, gastro …

Treatments for colorectal cancer (CRC) of all stages have evolved considerably over the
past two decades, resulting in improved long-term outcomes. After curative treatment …

Japanese mortality due to colorectal cancer is on the rise, surpassing 49,000 in 2015. Many
new treatment methods have been developed during recent decades. The Japanese …

Detection of circulating tumor DNA (ctDNA) after resection of stage II colon cancer may
identify patients at the highest risk of recurrence and help inform adjuvant treatment …

Colorectal cancer is a major cause of death in Japan, where it accounts for the largest
number of deaths from malignant neoplasms among women and the third largest number …

Colorectal endoscopic submucosal dissection (ESD) has become common in recent years.
Suitable lesions for endoscopic treatment include not only early colorectal carcinomas but …

Background Care for patients with colon and rectal cancer has improved in the last 20 years;
however considerable variation still exists in cancer management and outcome between …

Colorectal cancer is a major cause of death in Japan, where it accounts for the largest
number of deaths from malignant neoplasms in women and the third largest number in men …

Importance Intensive follow-up of patients after curative surgery for colorectal cancer is
common in clinical practice, but evidence of a survival benefit is limited. Objective To …

ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal
Cancer Page 1 ASCO 2006 Update of Recommendations for the Use of Tumor Markers in …